(Q35896986)

11 August 2017

1 reference

title

Mechanisms of activation of human natural killer cells against tumor and virus-infected cells (English)

1 reference

11 August 2017

Mechanisms of Activation of Human Natural Killer Cells Against Tumor and Virus-infected Cells (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

17 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

17 December 2022

author name string

D. Santoli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A153888

17 December 2022

H. Koprowski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A153888

17 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=153888

17 December 2022

publication date

1 January 1979

1 reference

full work available at URL

11 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1979.tb00269.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-065X.1979.tb00269.x/fullpdf

17 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

17 December 2022

published in

Immunological Reviews

1 reference

11 August 2017

volume

44

1 reference

11 August 2017

page(s)

125-163

1 reference

Interaction of aggregated -globulin with B lymphocytes

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Enhanced NK cell activity in mice injected with interferon and interferon inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Studies of Cell-mediated Immunity to Measles Virus by in Vitro Lymphocyte-mediated Cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

A comparative study of procedures for sheep erythrocyte-human-T-lymphocyte rosette formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Letter: HL-A 3,7 and lymphocyte cytotoxic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Immunological destruction of herpes simplex virus I infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

51Chromium-release microassay technique for cell-mediated immunity to mumps virus: correlation with humoral and delayed-type skin hypersensitivity responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Lysis of virus-infected target cells by antibody-dependent cellular cytotoxicity. I. General requirements of the reaction and temporal relationship between lethal hits and cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Acute infections in interferon-treated patients with osteosarcoma: preliminary report of a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Decreased Interferon Response by Lymphocytes from Children with Chronic Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1979.TB00269.X

Loss of specific natural cell-mediated cytotoxicity with absorption of natural antibodies from serum

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Cell-mediated and humoral immune reactions to human tumours

17 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y

17 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Lectin-dependent cellular cytotoxicity in man

17 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Cellular immunity to renal carcinomas in man

17 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Antitumour Effect of Lymphoid Cells activated by Interferon

17 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Ssytemic effects of intravenous polyriboinosinic-polyribocytidylic acid in man

17 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Separation of antiviral activity of human interferon from cell growth inhibitory effect

17 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Interferon preparations enhance phagocytosis in vivo

17 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

“Lymphokines”: Non-Antibody Mediators of Cellular Immunity generated by Lymphocyte Activation

17 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination

17 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Some Properties of Virus and Immune-Induced Human Lymphocyte Interferons

17 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Blocking of interferon production by chromatographically purified L cell interferon.

17 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

17 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Interferon and murine leukemia. I. Inhibitory effect of interferon preparations on development of friend leukemia in mice.

17 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Increased survival in mice inoculated with tumor cells and treated with interferon preparations

17 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells

17 December 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response

17 December 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations

17 December 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

17 December 2022

43

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

„Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell

17 December 2022

44

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes

17 December 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells

17 December 2022

51

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Variations in interferon production by lymphocytes from patients with chronic lymphatic leukaemia

17 December 2022

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Nonspecific acid esterase activity: A criterion for differentation of T and B lymphocytes in mouse lymph nodes

17 December 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies

17 December 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Natural Cytotoxic Reactivity of Rat Lymphocytes Against Syngeneic Gross Virus-Induced Lymphoma2

17 December 2022

63

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Natural cell-mediated cytotoxicity in rats. II.In vivo augmentation of NK-cell activity

17 December 2022

64

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Specificity of Natural Cytotoxic Reactivity of Normal Human Lymphocytes Against a Myeloid Leukemia Cell Line

17 December 2022

65

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells

17 December 2022

69

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes

17 December 2022

70

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Effect of priming on interferon inhibition of con A induced spleen cell blastogenesis.

17 December 2022

84

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Clinical and laboratory investigations on man: systemic administration of potent interferon to man.

17 December 2022

95

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Specificities in Human Cell-Mediated Cytotoxicity 2

17 December 2022

98

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

Tumour cell lines induce interferon in human lymphocytes

17 December 2022

103

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1979.TB00269.X

17 December 2022

Identifiers

1 reference

11 August 2017

1 reference